{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:25:25Z","timestamp":1779337525221,"version":"3.51.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/yco.0000000000000096","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T15:30:50Z","timestamp":1410276650000},"page":"400-405","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacotherapy for premature ejaculation"],"prefix":"10.1097","volume":"27","author":[{"given":"Marcel D.","family":"Waldinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210206","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1743-6109.2008.00901.x","article-title":"An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) Ad Hoc Committee for the definition of premature ejaculation.","volume":"5","author":"McMahon","year":"2008","journal-title":"J Sex Med"},{"key":"R2-4-20210206","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jsm.12524","article-title":"An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the definition of premature ejaculation.","volume":"11","author":"Serefoglu","year":"2014","journal-title":"J Sex Med"},{"key":"R4-4-20210206","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1743-6109.2008.00789.x","article-title":"H. The use of old and recent DSM definitions of premature ejaculation in observational studies: a contribution to the present debate for a new classification of PE in the DSM-V.","volume":"5","author":"Waldinger","year":"2008","journal-title":"J Sex Med"},{"key":"R6-4-20210206","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1743-6109.2010.02095.x","article-title":"Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey.","volume":"8","author":"Serefoglu","year":"2011","journal-title":"J Sex Med"},{"key":"R7-4-20210206","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jsm.12180","article-title":"Prevalence and factors associated with the complaint of premature ejaculation and the four premature ejaculation syndromes: a large observational study in China.","volume":"10","author":"Gao","year":"2013","journal-title":"J Sex Med"},{"key":"R8-4-20210206","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/13651509809115376","article-title":"An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation.","volume":"2","author":"Waldinger","year":"1998","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R10-4-20210206","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","article-title":"Dapoxetine Study GroupEfficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.","volume":"368","author":"Pryor","year":"2006","journal-title":"Lancet"},{"key":"R11-4-20210206","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1176\/ajp.151.9.1377","article-title":"Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study.","volume":"151","author":"Waldinger","year":"1994","journal-title":"Am J Psychiatry"},{"key":"R12-4-20210206","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.ijir.3901172","article-title":"Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis.","volume":"16","author":"Waldinger","year":"2004","journal-title":"Int J Impot Res"},{"key":"R13-4-20210206","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/j.1743-6109.2010.01975.x","article-title":"International Society for Sexual MedicineInternational Society for Sexual Medicines guidelines for the diagnosis and treatment of premature ejaculation.","volume":"7","author":"Althof","year":"2010","journal-title":"J Sex Med"},{"key":"R14-4-20210206","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jsm.12504","article-title":"An update of the International Society of Sexual Medicines Guidelines for the diagnosis and treatment of premature ejaculation (PE).","volume":"11","author":"Althof","year":"2014","journal-title":"J Sex Med"},{"key":"R15-4-20210206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14740338.4.2.337","article-title":"Selective serotonin re-uptake inhibitors and the risk of bleeding.","volume":"4","author":"Weinrieb","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"R16-4-20210206","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archinte.1995.00430060109017","article-title":"Paroxetine-induced priapism.","volume":"155","author":"Ahmad","year":"1995","journal-title":"Arch Intern Med"},{"key":"R17-4-20210206","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4088\/JCP.v59n1007e","article-title":"Priapism in a patient taking sertraline.","volume":"59","author":"Rand","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R18-4-20210206","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1743-6109.2007.00630.x","article-title":"Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors (SSRIs).","volume":"5","author":"Csoka","year":"2008","journal-title":"J Sex Med"},{"key":"R20-4-20210206","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3810\/pgm.2003.08.1474","article-title":"SSRI discontinuation syndrome; awareness as an approach to prevention.","volume":"114","author":"Ditto","year":"2003","journal-title":"Postgrad Med"},{"key":"R21-4-20210206","first-page":"255","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.","volume":"25","author":"Black","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"R22-4-20210206","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ijir.2011.35","article-title":"Escitalopram treatment for premature ejaculation has a negative effect on semen parameters.","volume":"23","author":"Koyuncu","year":"2011","journal-title":"Int J Impot Res"},{"key":"R23-4-20210206","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ijir.2012.12","article-title":"Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation.","volume":"24","author":"Koyuncu","year":"2012","journal-title":"Int J Impot Res"},{"key":"R24-4-20210206","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"},{"key":"R26-4-20210206","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2008.08165.x","article-title":"Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.","volume":"103","author":"Kaufman","year":"2009","journal-title":"BJU Int"},{"key":"R27-4-20210206","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1743-6109.2010.02097.x","article-title":"Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.","volume":"8","author":"McMahon","year":"2011","journal-title":"J Sex Med"},{"key":"R28-4-20210206","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.eururo.2013.08.018","article-title":"PAUSE Study TeamResults from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study.","volume":"65","author":"Mirone","year":"2014","journal-title":"Eur Urol"},{"key":"R29-4-20210206","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/aja.2012.174","article-title":"Efficacy and safety of local anaesthetics for premature ejaculation: a systematic review and meta-analysis.","volume":"15","author":"Xia","year":"2013","journal-title":"Asian J Androl"},{"key":"R30-4-20210206","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.urology.2012.12.028","article-title":"Topical anesthetic agents for premature ejaculation: a systematic review and meta-analysis.","volume":"81","author":"Pu","year":"2013","journal-title":"Urology"},{"key":"R31-4-20210206","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1464-410X.2003.04773.x","article-title":"Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study.","volume":"93","author":"Busato","year":"2004","journal-title":"BJU Int"},{"key":"R32-4-20210206","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1464-410X.2006.06583.x","article-title":"Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation.","volume":"99","author":"Dinsmore","year":"2007","journal-title":"BJU Int"},{"key":"R33-4-20210206","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1464-410X.2009.08456.x","article-title":"PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.","volume":"103","author":"Dinsmore","year":"2009","journal-title":"BJU Int"},{"key":"R34-4-20210206","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1111\/j.1743-6109.2010.01913.x","article-title":"Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study.","volume":"7","author":"Carson","year":"2010","journal-title":"J Sex Med"},{"key":"R35-4-20210206","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.urology.2012.05.035","article-title":"Efficacy and safety of tramadol for premature ejaculation: a systematic review and meta-analysis.","volume":"80","author":"Wu","year":"2012","journal-title":"Urology"},{"key":"R36-4-20210206","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1743-6109.2006.00424.x","article-title":"Tramadol HCL has promise in on-demand use to treat premature ejaculation.","volume":"5","author":"Salem","year":"2008","journal-title":"J Sex Med"},{"key":"R37-4-20210206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.urology.2011.09.031","article-title":"On-demand tramadol hydrochloride use in premature ejaculation treatment.","volume":"79","author":"Kaynar","year":"2012","journal-title":"Urology"},{"key":"R38-4-20210206","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.eururo.2011.08.039","article-title":"Tramadol ODT Study GroupA randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2min.","volume":"61","author":"Bar-Or","year":"2012","journal-title":"Eur Urol"},{"key":"R39-4-20210206","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/aja.2012.96","article-title":"Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation.","volume":"15","author":"Eassa","year":"2013","journal-title":"Asian J Androl"},{"key":"R40-4-20210206","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/j.1743-6109.2011.02628.x","article-title":"Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation A systematic review and meta-analysis.","volume":"9","author":"Asimakopoulos","year":"2012","journal-title":"J Sex Med"}],"container-title":["Current Opinion in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/YCO.0000000000000096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:36:50Z","timestamp":1620977810000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001504-201411000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/yco.0000000000000096","relation":{},"ISSN":["0951-7367"],"issn-type":[{"value":"0951-7367","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}